Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Axes of biological variation in diffuse large B cell lymphoma.
Journal: Cancer cell
Published: August 28, 2026
SOHO State of the Art Updates and Next Questions | Addressing the Transformative Questions in Aggressive B-Cell Lymphomas.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 18, 2026
Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma-Where we are and where we're headed.
Journal: Seminars in hematology
Published: December 12, 2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 13, 2025
Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: July 02, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.
Journal: ACS pharmacology & translational science
Published: June 10, 2025
Glofitamab with Polatuzumab Vedotin in Refractory Burkitt's Lymphoma.
Journal: The New England journal of medicine
Published: April 30, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.
Journal: British journal of haematology
Published: March 28, 2025
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas.
Journal: Leukemia & lymphoma
Published: February 03, 2025
Last Updated: 09/26/2026